Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (427)

« Back to Publications

The case for N-acetylcysteine in dengue associated liver injury: time for definitive evidence

McBride A. et al, (2026), Open Forum Infectious Diseases

Andes Virus on a Cruise Ship, what it Tells us About the Global Pandemic Preparedness Agenda.

Koopmans M. et al, (2026), The Lancet regional health. Europe, 66

Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review

Hassan MZ. et al, (2026), The Lancet Microbe, 7, 101295 - 101295

Performance of diagnostic procedures for bubonic plague in endemic settings in Madagascar: a prospective test accuracy sub-study within the IMASOY trial

Raberahona M. et al, (2026), Clinical Microbiology and Infection, 32, 638 - 643

Human infections with avian influenza A(H5) viruses with potential pandemic risk: 1997-2025.

Wang W. et al, (2026), National science review, 13

Chikungunya clinical management guidance: insights from a health system stakeholder study in Indonesia

Sukmaningrum E. et al, (2026), BMJ Global Health, 11, e019419 - e019419

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2026), The Lancet Infectious Diseases, 26, 34 - 45

Group‐Sequential Designs With an Externally‐Driven Change of Primary Endpoint

Yarahmadi A. et al, (2025), Statistics in Medicine, 44

Platform Trials to Assess Therapeutics in Patients Hospitalized With Influenza

Waite AAC. et al, (2025), The Journal of Infectious Diseases, 232, S254 - S261

Long-term follow-up of treatment comparisons in RECOVERY: a randomised, open-label, platform trial for patients hospitalised with COVID-19

Horby PW. et al, (2025)

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2025), The Lancet Infectious Diseases, 25, 1000 - 1010

Observational study on the clinical epidemiology of infectious acute encephalitis syndrome including Nipah virus disease, Bangladesh: BASE cohort study protocol

Hassan MZ. et al, (2025), BMJ Open, 15, e105903 - e105903

Vaccine Effects on In-hospital COVID-19 Outcomes

Gonçalves BP. et al, (2025), Epidemiology, 36, 646 - 649

Ciprofloxacin versus Aminoglycoside–Ciprofloxacin for Bubonic Plague

Randremanana RV. et al, (2025), New England Journal of Medicine, 393, 544 - 555

WHO pandemic agreement.

Norton A. et al, (2025), BMJ (Clinical research ed.), 390

Load More

1
2
3
4
5
6
7
...
»